Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 28.35
+0.10 (0.35%)
May 8, 2026, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.83 billion as of May 8, 2026. Its market cap has decreased by -1.39% in one year.
Market Cap
2.83B
Enterprise Value
2.30B
Revenue
1.94B
Ranking
n/a
PE Ratio
17.50
Stock Price
28.35
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.83B, an increase of 98.85%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.83B | -6.90% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.21B |
| Shine-On BioMedical | 3.18B |
| Genovate Biotechnology | 3.09B |
| TWi Biotechnology | 3.09B |
| Intech Biopharm | 3.05B |
| BRIM Biotechnology | 2.98B |
| Chunghwa Chemical Synthesis & Biotech | 2.98B |
| HeXun Biosciences | 2.86B |